Minerva Neurosciences Inc shares jumped after a biotech clinical trial of a drug similar to its new drug, MIN-301, improved Parkinson's disease symptoms in...
Chris Woollams Health Watch is an evidence-based, information-only website. We produce short synopses of the latest research in easy-to-understand language. We do NOT answer questions about individual illnesses. However, you can leave comments about the website.
Importantly, people with cancer should go to www.canceractive.com
People with cancer may apply to be 'buddied' by Chris Woollams in a Personal Prescription